EUCTR2005-003463-23-ES进行中（未招募）1 期
ADJUVANT TREATMENT OF FULLY RESECTED STAGE III COLON CANCER WITH FOLFOX-4 VERSUS FOLFOX-4 PLUS CETUXIMAB Tratamiento adyuvante con FOLFOX-4 versus FOLFOX-4 + cetuximab para el cáncer de colon en estadio III extirpado completamente - PETACC 8
Fédération Francophone de Cancérologie Digestive (FFCD)0 个研究点目标入组 2,000 人开始时间: 2006年2月16日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Age > or = 18 and <75 years
- •- Pathologically confirmed stage III adenocarcinoma of the colon, regardless of EGFR status,
- •- Curative R0 resection performed between 28 and 56 days prior to randomization
- •- No prior chemotherapy
- •- No prior abdominal or pelvic irradiation
- •- WHO performance status: 0 or 1
- •- Signed written informed consent obtained prior to any study specific screening procedures
- •- Patients with childbearing potential should use effective contraception
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Distant metastatic disease
- •- Inflammatory bowel disease
- •- Rectal cancer located within 15 cm from the anal verge by endoscopy or above the peritoneal reflection at surgery or having received radiation therapy prior to surgery
- •- Pregnant or breast-feeding woman
- •- Neuropathy
- •- Known hypersensitivity reaction to any of the components of study treatments.
研究者
相似试验
进行中（未招募）
1 期
ADJUVANT TREATMENT OF FULLY RESECTED STAGE III COLON CANCER WITH FOLFOX-4 VERSUS FOLFOX-4 PLUS CETUXIMABFULLY RESECTED STAGE III COLON CANCEREUCTR2005-003463-23-DEFédération Francophone de Cancérologie Digestive (FFCD)2,550
进行中（未招募）
1 期
ADJUVANT TREATMENT OF FULLY RESECTED STAGE III COLON CANCER WITH FOLFOX-4 VERSUS FOLFOX-4 PLUS CETUXIMAB - PETACC 8FULLY RESECTED STAGE III COLON CANCEREUCTR2005-003463-23-DKFédération Francophone de Cancérologie Digestive (FFCD)2,550
进行中（未招募）
1 期
ADJUVANT TREATMENT OF FULLY RESECTED STAGE III COLON CANCER WITH FOLFOX-4 VERSUS FOLFOX-4 PLUS CETUXIMAB - PETACC 8FULLY RESECTED STAGE III COLON CANCEREUCTR2005-003463-23-ATFédération Francophone de Cancérologie Digestive (FFCD)2,550
进行中（未招募）
1 期
ADJUVANT TREATMENT OF FULLY RESECTED STAGE III COLON CANCER WITH FOLFOX-4 VERSUS FOLFOX-4 PLUS CETUXIMAB - PETACC 8FULLY RESECTED STAGE III COLON CANCEREUCTR2005-003463-23-GBFédération Francophone de Cancérologie Digestive (FFCD)2,550
进行中（未招募）
1 期
ADJUVANT TREATMENT OF FULLY RESECTED STAGE III COLON CANCER WITH FOLFOX-4 VERSUS FOLFOX-4 PLUS CETUXIMAB - PETACC 8EUCTR2005-003463-23-BEFédération Francophone de Cancérologie Digestive (FFCD)2,550